Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R1CG
|
|||
| Former ID |
DCL001150
|
|||
| Drug Name |
ASG-22ME
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
Seattle Genetics; Agensys
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Nectin cell adhesion molecule 4 (NECTIN4) | Target Info | . | [1] |
| KEGG Pathway | Adherens junction | |||
| Reactome | Adherens junctions interactions | |||
| WikiPathways | Cell junction organization | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2011 Pipeline of Seattle Genetics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.